FCF Fox Corporate Finance hosted a capital markets conference in partnership with Hogan Lovells to highlight the recent pre-IPO / IPO financing trends in the Life Science industry.
The findings of the latest FCF Venture Capital and IPO studies were presented by Mathias Schott and Arno Fuchs.
The FCF Venture Capital Report addresses the current financing trends in the Life Science industry, investigating the subsector activity, deal highlights and investor engagements in Europe and the US.
The FCF IPO Report examines the recent developments of Life Science IPOs in Europe and the US, with a detailed analysis of the key characteristics of public offerings, post-IPO share price performance and upcoming IPO candidates.
Peter Huber and Prof. Michael Schlitt elaborated on important legal aspects of pre-IPO and IPO financing rounds.
To receive a copy of the reports, please contact Veronika Degle.